Posttranscriptional Regulation of RNA Binding Proteins in Heart Failure
心力衰竭中 RNA 结合蛋白的转录后调控
基本信息
- 批准号:10656393
- 负责人:
- 金额:$ 37.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-15 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAdultAffectAttenuatedCardiacCardiac MyocytesCell Culture SystemClinicalComplexCultured CellsDNA Sequence AlterationDataDefectDevelopmentDilated CardiomyopathyElderlyEventFunctional disorderGenesGeneticGenetic TranscriptionHeartHeart failureHospitalizationImmunoprecipitationImpairmentIn VitroInduced MutationKnock-inKnock-in MouseKnockout MiceLinkMass Spectrum AnalysisMediatingMessenger RNAModelingModificationMolecularMorbidity - disease rateMusMuscleMutationPathogenesisPathologicPatientsPhosphorylationPhosphorylation SitePilot ProjectsPost-Transcriptional RegulationPreventionProcessProtein IsoformsProteinsPublic HealthRNARNA Recognition MotifRNA SplicingRNA metabolismRNA-Binding ProteinsRattusRegulationRoleSeriesSerineSiteSystolic heart failureTechnologyTestingTimeTranscriptTranscription ProcessTranslationsTransportationUntranslated RNAWorkcofactorconditional knockoutconnectincrosslinkfetalheart functionin vivoin vivo Modelinherited cardiomyopathyinhibitorinnovationinsightmRNA Precursormimeticsmortalitymouse modelnew therapeutic targetnovelnovel therapeuticsnucleocytoplasmic transportposttranscriptionalprotein protein interactionpublic health relevancetraffickingtranscriptome sequencing
项目摘要
Summary
Heart failure is a major public heath issue worldwide and its morbidity and mortality are unacceptably high, and
remains the leading cause of morbidity, mortality, and hospitalization among adults and the elderly. Given
these clinical observations, development of new therapeutic targets is urgently required and understanding the
molecular mechanisms responsible for heart failure development and progression is critically important to
develop new therapeutic targets. For genes to produce their final functional products (proteins or non-coding
RNAs), the RNA transcripts need to be extensively processed after transcription, including splicing,
modification, transportation and translation. RNA binding proteins (RBPs) are important regulators in each step
of the complex processes of RNA metabolism and are being recognized as emerging key players in the
pathogenesis of heart failure. Although transcriptional changes have been extensively studied in the failing
hearts, very little is known about the role of posttranscriptional events in the remodeling heart. In this proposal,
we will systematically investigate the role of RNA binding protein 20 (RBM20) in the pathogenesis of heart
failure. We hypothesize that RBM20 phosphorylation and mutations on phosphorylation sites alter the
posttranscriptional process and lead to cardiac remodeling, and RBM20 isoforms and cofactors regulate fetal
gene re-expression in adult heart to promote heart failure. To test the hypothesis, we have created mutation
knock-in (KI) and double knockout mouse models to evaluate functional roles of posttranscriptional event
changes in cardiac remodeling, and determine the genes and proteins affected by the posttranscriptional
changes. KI mice will be used to evaluate the translational value with the inhibitor of nuclear transport for
RBM20-meidated nucleo-cytoplasmic trafficking. Two specific aims are proposed in this proposal. 1) Determine
the functional roles of RBM20 phosphorylation and genetic mutations on phosphorylation sites in the
pathogenesis of heart failure; 2) Determine the molecular/cellular mechanisms of RBM20 mediated
posttranscriptional regulation of heart failure through cofactors and RBM20 isoforms. The achievement of the
proposed aims will gain new information regarding RBPs-mediated posttranscriptional regulation in the
pathogenesis of heart failure and provide a new paradigm for the mechanistic study on genetic mutations-
induced heart failure.
总结
心力衰竭是世界范围内的主要公共健康问题,其发病率和死亡率高得不可接受,
仍然是成人和老年人发病、死亡和住院的主要原因。给定
根据这些临床观察,迫切需要开发新的治疗靶点,并了解
负责心力衰竭发生和进展的分子机制对于
开发新的治疗靶点。对于基因产生其最终功能产物(蛋白质或非编码蛋白质),
RNA),RNA转录物需要在转录后进行广泛的加工,包括剪接,
修改、运输和翻译。RNA结合蛋白(RBP)是这一过程的重要调节因子
RNA代谢的复杂过程,并被认为是新兴的关键球员,
心力衰竭的发病机制。虽然转录变化已经被广泛研究,在失败的
心脏,很少有人知道的作用,转录后事件在重塑心脏。在这一提议中,
本研究拟系统地探讨RNA结合蛋白20(RBM 20)在心脏病发病机制中的作用,
失败我们假设RBM 20磷酸化和磷酸化位点的突变改变了
RBM 20亚型和辅因子调节胎儿心肌细胞凋亡,
基因在成人心脏中的重新表达促进心力衰竭。为了验证这个假设,我们创造了突变
敲入(KI)和双敲除小鼠模型,以评估转录后事件功能作用
心脏重塑的变化,并确定受转录后影响的基因和蛋白质。
变化KI小鼠将用于评价核转运抑制剂的翻译值,
RBM 20介导的核质运输。该提案提出了两个具体目标。1)确定
RBM 20磷酸化和磷酸化位点上的基因突变在细胞中的功能作用,
心力衰竭的发病机制; 2)确定RBM 20介导的心力衰竭的分子/细胞机制。
通过辅因子和RBM 20亚型对心力衰竭的转录后调节。的实现
提出的目标将获得有关RBP介导的转录后调控的新信息,
为基因突变的机制研究提供了新的范式-
导致心力衰竭。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
RBM20 phosphorylation and its role in nucleocytoplasmic transport and cardiac pathogenesis.
- DOI:10.1096/fj.202101811rr
- 发表时间:2022-05
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
RBM20-Mediated Pre-mRNA Splicing Has Muscle-Specificity and Differential Hormonal Responses between Muscles and in Muscle Cell Cultures.
- DOI:10.3390/ijms22062928
- 发表时间:2021-03-13
- 期刊:
- 影响因子:5.6
- 作者:Maimaiti R;Zhu C;Zhang Y;Ding Q;Guo W
- 通讯作者:Guo W
Disruption of the nuclear localization signal in RBM20 is causative in dilated cardiomyopathy.
- DOI:10.1172/jci.insight.170001
- 发表时间:2023-07-10
- 期刊:
- 影响因子:8
- 作者:Zhang Y;Gregorich ZR;Wang Y;Braz CU;Zhang J;Liu Y;Liu P;Shen J;Aori N;Hacker TA;Granzier H;Guo W
- 通讯作者:Guo W
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hasan Khatib其他文献
Hasan Khatib的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 37.81万 - 项目类别:
Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
- 批准号:
2230829 - 财政年份:2023
- 资助金额:
$ 37.81万 - 项目类别:
Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 37.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 37.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 37.81万 - 项目类别:
Grant-in-Aid for Scientific Research (C)